Evidence map›Paper›PMID 37795023›Full record

ArticleFrontiers in pharmacology2023

Mechanistic insights into MARK4 inhibition by galantamine toward therapeutic targeting of Alzheimer's disease.

Mohd Adnan, Debarati DasGupta, Saleha Anwar, Anas Shamsi, Arif Jamal Siddiqui, Mejdi Snoussi, Fevzi Bardakci, Mitesh Patel, Md Imtaiyaz Hassan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Tauopathy in AD: Therapeutic Potential of MARK-4.Current Alzheimer research · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Mohd AdnanDepartment of Biology, College of Science, University of Ha'il, Ha'il, Saudi Arabia.
Debarati DasGuptaCollege of Pharmacy, University of Michigan, Ann Arbor, MI, United States.
Saleha AnwarCentre for Interdisciplinary Research in Basic Sciences, New Delhi, India.
Anas ShamsiCentre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab Emirates.
Arif Jamal SiddiquiDepartment of Biology, College of Science, University of Ha'il, Ha'il, Saudi Arabia.
Mejdi SnoussiDepartment of Biology, College of Science, University of Ha'il, Ha'il, Saudi Arabia.
Fevzi BardakciDepartment of Biology, College of Science, University of Ha'il, Ha'il, Saudi Arabia.
Mitesh PatelResearch and Development Cell, Department of Biotechnology, Parul Institute of Applied Sciences, Parul University, Vadodara, India.
Md Imtaiyaz HassanCentre for Interdisciplinary Research in Basic Sciences, New Delhi, India.
University of Ha'il · SAAjman University · AEParul University · INUniversity of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

acetylcholinesterase inhibitorsAlzheimer’s diseaseisothermal titration calorimetrykinase inhibitorsmolecular dynamics simulation

Identifiers

PMID37795023
PMCPMC10546050
OpenAlexW4386855851

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.